To the Editor: The effects of endogenous and exogenous NO on ventricular function have gained high interest considering normal heart physiology and the eventual extension of new knowledge to pharmacology and therapy by using NO donors or inhibitors of NO endogenous production. The paper "Cardiac mitochondrial nitric oxide: a regulator of heart rate?" by Fellet et al. 1 addresses the role of NO in the regulation of heart rate, reporting a negative chronotropic effect of endogenous NO, according to the increase in heart rate after L-NAME (N G -nitro-larginine methyl ester) admini stration and to the association of reduced heart rates with increased mitochondrial nitric oxide synthase (mtNOS) activities. The review integrates three papers (refs. 25, 30, and 35 in Fellet et al. 1 ) in which the effects of the NOS-inhibitor L-NAME (7.5 mg/kg IV) on heart rate and blood pressure were followed in rats without autonomic nervous system regulation, as produced by bilateral vagotomy and by continous hexamethonium bromide injection. Denervated rats show a significant increase in heart rate after L-NAME injection, which is not seen in normal rats due to the vagal and adrenergic regulation of heart rate. The authors' observation and hypothesis of a negative chronotropic effect of endogenous NO challenges a claim of a NO positive chronotropic effect 2 and constitutes a stimulating contribution for the study of the NO effects on heart ventricular function.
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The 1998 Nobel Prize in Physiology or Medicine was awarded to Furchgott, Ignarro and Murad for their discovery of NO as a signaling molecule in the cardiovascular system. However, there is still a large uncertainty concerning the whole effects of NO in the basic heart functions of contractility, relaxation and heart rate. On the positive side, it is clear that heart NO has an inhibitory function on the positive chronotropic and inotropic respon ses depending on β-adrenergic receptors. For the rest, as the authors mention, there are a large number of observations in a variety of conditions and of experimental and clinical conditions that do not support a unique interpretation.
The paper also brings up the question of which genomic NOS are expressed in the heart and what are the physiological roles of the NOS isoforms. The early idea that the three forms of genomic NOS (neuronal NOS, inducible NOS, and endothelial NOS) are expressed and functionally active in the heart is now under revision with the additional recognition that NOS expression is different in ventricular cardiomyocytes and in cardiac microvascular endothelial cells. Zaobornyj et al. 3 reported that the capacity to produce NO in homogenized ventricles is 55% accounted by mtNOS activity, 43% by the endothelial NOS of sarcoplasmic reticulum, and 2% by cytosolic NOS. The marked and fast effect of autonomic denervation on mtNOS activity 3 is associated with a positive chronotropic effect after L-NAME injection (18% increase in heart rate) and, according to the authors hypothesis, constitute the molecular mechanism for the observed increased heart rate. A role of NO in mitochondrial biogenesis 4 is a concept with straightforward applications in heart remodeling after adaptation to chronic hypoxia or as recovery after infarction.
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